The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Clarke, Dermot Martin
    Solicitor born in August 1962
    Individual (3 offsprings)
    Officer
    2000-09-07 ~ now
    OF - Director → CIF 0
    Clarke, Dermot Martin
    Individual (3 offsprings)
    Officer
    2000-09-07 ~ now
    OF - Secretary → CIF 0
  • 2
    Clarke, Julia Elizabeth Gervaise
    Market Researcher born in January 1963
    Individual (1 offspring)
    Officer
    2000-09-07 ~ now
    OF - Director → CIF 0
    Mrs Julia Clarke
    Born in January 1963
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Has significant influence or controlCIF 0
Ceased 2
parent relation
Company in focus

PHARMA MED RESEARCH LIMITED

Standard Industrial Classification
73200 - Market Research And Public Opinion Polling
Brief company account
Property, Plant & Equipment
-1 GBP2023-09-30
3,792 GBP2022-09-30
Debtors
20,368 GBP2023-09-30
0 GBP2022-09-30
Cash at bank and in hand
1,127 GBP2023-09-30
300 GBP2022-09-30
Current Assets
21,495 GBP2023-09-30
300 GBP2022-09-30
Creditors
Current
-31,377 GBP2023-09-30
-12,545 GBP2022-09-30
Net Current Assets/Liabilities
-9,882 GBP2023-09-30
-12,245 GBP2022-09-30
Total Assets Less Current Liabilities
-9,883 GBP2023-09-30
-8,453 GBP2022-09-30
Equity
Called up share capital
10 GBP2023-09-30
10 GBP2022-09-30
Retained earnings (accumulated losses)
-9,893 GBP2023-09-30
-8,463 GBP2022-09-30
Equity
-9,883 GBP2023-09-30
-8,453 GBP2022-09-30
Average Number of Employees
22022-10-01 ~ 2023-09-30
Property, Plant & Equipment - Gross Cost
16,818 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
16,819 GBP2023-09-30
13,026 GBP2022-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3,793 GBP2022-10-01 ~ 2023-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10 shares2023-09-30
Par Value of Share
Class 1 ordinary share
1 GBP2022-10-01 ~ 2023-09-30
Equity
Called up share capital
10 GBP2023-09-30
10 GBP2022-09-30

  • PHARMA MED RESEARCH LIMITED
    Info
    Registered number 04067211
    Trigg House 54 Hall Road, Leckhampton, Cheltenham, Gloucestershire GL53 0HE
    Private Limited Company incorporated on 2000-09-07 (24 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.